Immunology in medical practice. IV. Inflammatory bowel disease: Pathogenic leads to specific therapy;Immunologie in de medische praktijk. IV. Inflammatoire darmziekten: Pathogenetische aanknopingspunten voor specifieke therapie

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 41, 1997, Pages 1956-1959

  Van Deventer, S J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CROHN DISEASE; DRUG EFFICACY; ENTERITIS; HUMAN; IMMUNOTHERAPY; SHORT SURVEY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKINS; MICE; MICE, KNOCKOUT; MICE, SCID; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030846458     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95:55-65.
2. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 1996;183: 2605-16.
3. Berden JHM. Immunologie in de medische praktijk. III. Lupus erythematodes disseminatus: gestoorde apoptose? Ned Tijdschr Geneeskd 1997;141:1848-54.
4. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17:138-46.
5. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109: 1344-67.
6. Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996; 26:934-8.
7. Leach MW, Bean AG, Mauze S, Coffman RL, Powrie F. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am J Pathol 1996;148:1503-15.
8. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. Inhibition of TH1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994;1:553-62
9. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994;179:589-600.
10. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
11. Berg DJ, Davidson N, Kuhn R, Muller W, Menons S, Holland G, et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) Th1-like responses. J Clin Invest 1996;98:1010-20.
12. Stronkhorst A, Radema SA, Yong SL, Sanders M, Berge RJM ten, Tytgat GNJ. et al CD4 antibody treatment in Crohn's disease. Gut 1997;40:320-7.
13. Deventer SJH van, Elson CO, Fedorak R Safety and tolerance of intravenous interleukm-10 in patients with steroid-refractory Crohn's disease. Gastroenterology 1997;113:430-3.
14. Deventer SJH van. Tumour necrosis factor and Crohn's disease. Gut 1997;40:443-8.
15. Dullemen HM van, Deventer SJH van, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ. et al. Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
16. Targan SR, Rutgeerts P, Hanauer SB, Deventer SJH van, Mayer L, Present DH, et al. A Multicenter trial of anti-tumor necrosis factor (TNF) antibody (cA2) for treatment of patients with active Crohn's disease. Gastroenterology 1996;110:A1026.